| Description : |
Predicted to enable enzyme binding activity; nucleic acid binding activity; and serine-type endopeptidase inhibitor activity. Involved in negative regulation of inflammatory response. Predicted to be located in Golgi apparatus. Predicted to be active in extracellular space. Biomarker of chronic obstructive pulmonary disease; endophthalmitis; middle cerebral artery infarction; myocardial infarction; and polycystic ovary syndrome. Orthologous to human SLPI (secretory leukocyte peptidase inhibitor). |
| Source : |
E. coli |
| Species : |
Rat |
| Tag : |
N-His&GST |
| Form : |
Freeze-dried powder |
| Molecular Mass : |
Predicted Molecular Mass: 41.4 kDa
Accurate Molecular Mass: 44 kDa |
| Protein length : |
Gly26-Val130 |
| Purity : |
> 90% |
| Applications : |
Positive Control; Immunogen; SDS-PAGE; WB. |
| Stability : |
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 centigrade for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition. |
| Storage : |
Avoid repeated freeze/thaw cycles. Store at 2-8 centigrade for one month. Aliquot and store at -80 centigrade for 12 months. |
| Storage Buffer : |
20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300. |
| Reconstitution : |
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex. |
